Representative before the EPO
Partner/Owner

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 70 EP applications Hugh Goodfellow has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 26, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11835385

THERAPEUTIC COMPOSITIONS FOR DIABETIC SYMMETRICAL POLYNEUROPATHY

IPC classification:
A61K 31/46, A61K 31/496, A61K 31/5513, A61P 25/02, C07D 417/12, C07D 451/10, C07D 471/04, C07D 495/04
Applicant:
University of Manitoba
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP11848160

COMPOSITIONS AND METHODS FOR SPINE FUSION PROCEDURES

IPC classification:
A61B 17/58
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Lavoix Munich
Status:
EXAMINATION REQUESTED
EP12739329

PATHOGENIC MYCOBACTERIA-DERIVED MANNOSE-CAPPED LIPOARABINOMANNAN ANTIGEN BINDING PROTEINS

IPC classification:
A61K 39/40, A61P 31/06, C07K 16/12, G01N 33/569
Applicant:
National University of Singapore
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12707954

ADVANCED ACTIVE LIPOSOMAL LOADING OF POORLY WATER-SOLUBLE SUBSTANCES

IPC classification:
A61K 9/127, A61K 47/48
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Nederlandsch Octrooibureau N.V.
Status:
GRANT OF PATENT INTENDED
EP13156603

Hyperphotosynthetic organisms

IPC classification:
C12N 1/21, C12N 9/00, C12N 15/53
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12785579

PROCESS FOR PURIFYING HEPARAN-N-SULFATASE

IPC classification:
A61K 38/47, C12N 9/24
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Graham James Lock, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12728007

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

IPC classification:
A61K 31/131, A61K 31/132, A61K 31/215, A61K 31/56, A61K 38/00, A61K 38/16, A61K 38/43
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12729758

MCAM ANTAGONISTS AND METHODS OF TREATMENT

IPC classification:
C07K 16/30
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11848839

HUMAN MONOCLONAL ANTIBODY WITH SPECIFICITY FOR DENGUE VIRUS SEROTYPE 1 E PROTEIN AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/42, A61K 45/06, A61P 31/14, C07K 16/10, C12N 15/13, C12P 21/08
Applicant:
National University of Singapore
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12818250

PENTRAXIN 3 ASSOCIATION WITH ASTHMA

IPC classification:
G01N 33/48
Applicant:
University of Michigan
Applicant:
Janssen Biotech, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12710838

COMBINATION THERAPIES FOR HEMATOLOGIC MALIGNANCIES

IPC classification:
A61K 31/4184, A61K 31/4439, A61K 31/52, A61K 39/00, A61K 45/06, A61P 35/00, A61P 35/02
Applicant:
Gilead Calistoga LLC
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
APPLICATION WITHDRAWN
EP12714910

METHODS AND COMPOSITIONS FOR NORMALIZATION OF TUMOR VASCULATURE BY INHIBITION OF LOXL2

IPC classification:
A61K 31/7088, C07K 16/40
Applicant:
Gilead Biologics, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11845391

TREATMENT OF JAK2-MEDIATED CONDITIONS

IPC classification:
A61K 31/444, A61K 31/505, A61K 31/506, A61K 31/5377, A61K 31/541, A61P 7/06
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Joseph Lenthall, Mewburn Ellis LLP
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
EXAMINATION REQUESTED
EP12828354

PROCESS FOR RECOVERING SALT DURING A LIGNOCELLULOSIC CONVERSION PROCESS

IPC classification:
C02F 1/04, C02F 1/52, C05F 5/00, C05F 7/00, C12P 7/10, C12P 19/00, D21C 9/00, F22B 1/00, F22B 33/18
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP12836507

COMPOUNDS FOR IMPROVED VIRAL TRANSDUCTION

IPC classification:
C12N 5/02, C12N 5/071, C12N 7/01
Applicant:
Bluebird Bio, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Status:
The patent has been granted
EP11838922

A2A ANTAGONISTS AS COGNITION AND MOTOR FUNCTION ENHANCERS

IPC classification:
A61K 9/00, A61K 31/198, A61K 31/44
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12847487

ANTISENSE OLIGONUCLEOTIDE MODULATORS OF SEROTONIN RECEPTOR 2C AND USES THEREOF

IPC classification:
C07H 21/00, C12N 15/113
Applicant:
Shire Human Genetic Therapies Inc
Applicant:
University of Kentucky
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12757516

METHODS AND USE OF BIFUNCTIONAL ENZYME-BUILDING CLAMP-SHAPED MOLECULES

IPC classification:
A01N 43/54, A61K 31/497, A61K 31/517, A61P 35/00, C07D 401/00
Applicant:
University of Pennsylvania
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP11760822

PRODRUGS OF GUANFACINE

IPC classification:
A61K 31/155, C07C 279/24, C07D 233/64
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11860324

NON-AQUEOUS HIGH CONCENTRATION REDUCED VISCOSITY SUSPENSION FORMULATIONS OF ANTIBODIES

IPC classification:
A61K 9/00, A61K 9/10, A61K 9/14, A61K 9/19, A61K 38/38, A61K 39/395, A61K 47/26, A61K 47/42, A61K 47/44
Applicant:
Janssen Biotech, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13197830

Fuel composition comprising a mixture of n-alkanes

IPC classification:
C07C 11/02, C10L 1/02, C12N 1/21, C12N 9/02, C12N 9/04, C12N 9/88, C12P 5/02, C12P 7/04
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12860175

REACTIVE OXYGEN SPECIES-RESISTANT MICROORGANISMS

IPC classification:
C07H 21/04, C12N 1/20, C12N 1/21, C12N 15/31, C12N 15/52, C12P 7/06
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14173039

Therapeutic compounds

IPC classification:
A61K 31/196, A61K 31/4192, A61K 31/426, A61K 31/435, A61K 31/5375, A61P 9/10, A61P 11/00, A61P 13/12, A61P 17/02, A61P 29/00, A61P 35/00, A61P 43/00, C07C 231/02, C07C 235/38, C07D 213/16, C07D 213/643, C07D 253/04, C07D 261/08, C07D 295/03
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Ström & Gulliksson AB
Status:
EXAMINATION IN PROGRESS
EP14163968

Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters

IPC classification:
A61K 31/443, A61P 11/00, C07D 405/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12794811

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

IPC classification:
A61K 31/405, A61K 31/553, A61P 1/00, A61P 3/00, A61P 11/00, A61P 25/00, A61P 27/00, A61P 35/00, C07D 405/12, C07D 405/14, C07D 498/04
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12196511

Process for producing cycloalkylcarboxiamido-pyridine benzoic acids

IPC classification:
C07D 213/73, C07D 405/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11821115

USE OF INTERLEUKIN-22 IN TREATING VIRAL HEPATITIS

IPC classification:
A61K 38/20, A61P 1/16, A61P 31/12, C07K 14/54
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP14168373

Modulators of CFTR

IPC classification:
A61K 31/444, A61P 11/00, A61P 37/00, C07D 401/04, C07D 405/14
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12787303

USE OF (N- [2, 4 -BIS (1, 1 -DIMETHYLETHYL) - 5 - HYDROXYPHENYL]- 1, 4 - DIHYDRO - 4 - OXOQUINOLINE - 3 - CARBOXAMIDE) FOR TREATING CFTR MEDIATED DISEASES

IPC classification:
A61K 31/47
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP13741481

GENERATION OF PHOTORECEPTORS FROM HUMAN RETINAL PROGENITOR CELLS USING POLYCAPROLACTONE SUBSTRATES

IPC classification:
A01N 63/00, A61F 2/00, C12N 5/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13703243

FORMULATIONS OF 3-(6-(1-(2.2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/28, A61K 31/443, C07D 213/75, C07D 405/12, C07D 405/14
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13708625

PHARMACEUTICAL COMPOSITION AND ADMINISTRATION THEREOF

IPC classification:
A61K 9/16, A61K 31/47, A61K 47/02, A61K 47/26, A61K 47/32, A61K 47/38
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13755552

VARIANTS OF PROTHYMOSIN ALPHA AND METHODS OF USING SAME

IPC classification:
A61K 38/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Fabrizio Minoja, Bianchetti Bracco Minoja Srl
Status:
GRANT OF PATENT INTENDED
EP12752152

ASSAYS FOR ANTIBODIES WHICH BIND TO THERAPEUTIC AGENTS

IPC classification:
C12N 11/00, G01N 33/543, G01N 33/68
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Graham James Lock, Fry Heath & Spence LLP
Status:
GRANT OF PATENT INTENDED
EP13703505

TFPI INHIBITORS AND METHODS OF USE

IPC classification:
A61K 38/10, A61P 7/02, C07K 7/08
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP13778780

HUMAN ANTIBODIES AND SPECIFIC BINDING SEQUENCES THEREOF FOR USE IN STROKE AND ISCHEMIA OR ISCHEMIC CONDITIONS

IPC classification:
A61K 39/395
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Andrew John Teuten, Sagittarius IP
Status:
The patent has been granted
EP13788302

HETEROMULTIMER CONSTRUCTS OF IMMUNOGLOBULIN HEAVY CHAINS WITH MUTATIONS IN THE FC DOMAIN

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/02, C07K 16/12, C07K 16/24, C07K 16/28, C07K 16/30, C07K 16/46
Applicant:
Zymeworks Inc
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13819634

ANTI-SIGLEC-15 ANTIBODIES

IPC classification:
A61K 39/395, A61P 19/08, C07K 16/28, C12N 5/10, C12N 15/13, C12N 15/85
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
William Gerrit Arends, Marks & Clerk LLP
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13829280

METHODS AND SYSTEMS FOR SCREENING COMPOSITIONS COMPRISING NON-ANTICOAGULANT SULFATED POLYSACCHARIDES

IPC classification:
G01N 33/48, G01N 33/50, G01N 33/86
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Stevens Hewlett & Perkins
Status:
EXAMINATION IN PROGRESS
EP12745098

SOLAR THERMAL ENERGY CAPTURE SYSTEM WITH OVERHEATING PROTECTION AND COLD TEMPERATURE BYPASS

IPC classification:
F24D 17/00, F24D 19/08, F24D 19/10, F24J 2/34, F24J 2/40, F24J 2/46, H02S 40/44
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP13812072

APPARATUS AND METHOD FOR BLOOD COLLECTION

IPC classification:
A61B 5/15
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11764933

ATROPISOMERS OF PI3K-INHIBITING COMPOUNDS

IPC classification:
A61K 31/4985, A61P 29/00, C07D 487/04
Applicant:
Gilead Calistoga LLC
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13855452

DIGITAL ANALYSIS OF MOLECULAR ANALYTES USING SINGLE MOLECULE DETECTION

IPC classification:
G06F 19/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP14740167

EVALUATION, ASSAYS AND TREATMENT OF PKAL-MEDIATED DISORDERS

IPC classification:
C12Q 1/56, G01N 33/48, G01N 33/50
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP14740444

EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS

IPC classification:
C07K 16/40
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP14769180

METHODS OF CELL CULTURE

IPC classification:
A61K 39/395
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14776142

METHODS OF CELL CULTURE

IPC classification:
C12N 5/00, C12N 5/02, C12P 1/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14775649

METHODS OF CELL CULTURE

IPC classification:
C12N 5/00, C12N 5/07, C12P 21/04
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14721659

CD14+ CELL COMPOSITIONS AND METHODS OF USING SAME

IPC classification:
A61K 35/28, A61P 9/10, C12N 5/071, C12N 5/0775, C12N 5/0786
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP14718260

METHOD OF CHARACTERIZING LYSOSOMAL ENZYMES

IPC classification:
C07K 1/26, C12N 9/24
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP15177547

CANCER THERAPIES AND PHARMACEUTICAL COMPOSITIONS USED THEREIN

IPC classification:
A61K 31/337, A61K 31/4745, A61K 31/475, A61K 31/573, A61K 31/575, A61K 31/70, A61K 31/7088, A61K 39/395, A61K 45/06, A61P 35/00, C07K 16/28
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13167785

Modulators of ATP-binding cassette transporters

IPC classification:
A61K 31/404, A61P 31/00, C07D 405/12, C07D 405/14, C07D 471/04
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14803492

PHARMACEUTICAL COMPOSITIONS COMPRISING PYROPHOSPHATE

IPC classification:
A61K 39/395, A61K 47/42, C01B 25/42
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP10859722

IMMUNOGLOBULIN CLEAVAGE FRAGMENTS VACCINE COMPOSITIONS

IPC classification:
A61K 39/00, C07K 16/06, C07K 16/18, C07K 16/42
Applicant:
Janssen Biotech, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP12700043

TUMOUR CELL AND TISSUE CULTURE

IPC classification:
C12N 5/09, G01N 33/50
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12188920

Pyridyl derivatives as CFTR modulators

IPC classification:
A61K 31/44, A61K 31/4427, A61P 43/00, C07D 213/75, C07D 405/12, C07D 405/14, C07D 413/14
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11799035

CNS DELIVERY OF THERAPEUTIC AGENTS

IPC classification:
A61K 9/00, A61K 9/19, A61K 38/46, A61K 38/47, A61P 25/00, A61P 25/28
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12196539

Process for producing cycloalkylcarboxiamido-pyridine benzoic acids

IPC classification:
C07D 213/73, C07D 405/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12196502

Process for producing cycloalkylcarboxiamido-pyridine benzoic acids

IPC classification:
C07D 213/73, C07D 405/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11810502

ANTIFUNGAL AND ANTIPARASITIC POLYENE MACROLIDES

IPC classification:
A61K 9/00, A61K 9/08, A61K 9/20, A61K 31/70, C07D 493/08, C07H 17/08
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP13157678

Compositions suitable for treatment of spinal disease, disorder or condition

IPC classification:
A61K 35/54, A61L 27/36, A61L 27/38, A61L 27/54, C12N 5/071
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP15709067

PEPTIDES AND METHODS OF USE

IPC classification:
A61K 38/00, C07K 7/08, C07K 14/745
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP15769534

COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC MACULAR EDEMA

IPC classification:
A61K 39/395, A61P 27/02, C07K 16/40
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15726501

SUBSTRATE-MEDIATED REACTORS FOR BIOASSAYS

IPC classification:
G01N 33/538, G01N 33/543
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16195158

TFPI INHIBITORS AND METHODS OF USE

IPC classification:
A61K 38/18, C07K 14/81
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP15831523

MODIFIED IL-2 VARIANTS THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

IPC classification:
A61K 38/20, C07K 14/55, C07K 17/08
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15759685

IODOPHOR COMPOSITION WITH IMPROVED STABILITY IN THE PRESENCE OF ORGANIC MATERIAL

IPC classification:
A01N 25/22, A01N 59/12, A01N 59/24, A01P 1/00, A23C 7/00, A61K 8/20, A61K 8/22, A61K 9/00, A61K 33/18
Applicant:
National University of Ireland, Galway (National University of Ireland Galway)
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tomkins & Co
Status:
Request for examination was made
EP17150192

CELLS ON A SUPPORT MATRIX FOR TISSUE REPAIR

IPC classification:
A61K 35/12, A61L 27/38, C12N 5/00
Applicant:
Verigen AG
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Cooley (UK) LLP
Status:
The application has been published
EP15823264

ENZYMATIC ACTIVITY ASSAYS FOR GLUCOCEREBROSIDASE

IPC classification:
C12Q 1/34
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15823270

ENZYMATIC ACTIVITY ASSAYS FOR I2S

IPC classification:
C12Q 1/34
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made

Please Sign in to use this feature